News ArchivesRead News

Your Parkinson's News Update for the Week of 7.1.19

Monday July 01, 2019
Scientists Track Parkinson's Journey from Gut to Brain in Mice
Medical News Today
A paper in the journal Neuron describes the mouse model and study findings. "Since this model starts in the gut," says co-senior study author Ted M. Dawson, professor of neurology at Johns Hopkins University School of Medicine, "one can use it [to] study the full spectrum and time course of the pathogenesis of Parkinson's." Such a model could allow researchers to test ways to halt Parkinson's at different stages, from before symptoms emerge to well after diagnosis.
Microbes in Saliva May Offer Way of Detecting and Understanding Early Stages of Parkinson’s, Study Says
Parkinson's News Today
“'I think we’ve entered a new era in terms of neurodegenerative disease research and are now starting to consider the oral microbiome and the bacteria and other biota that are there as a ripe place for discovery of potential risk factors,' Frank Middleton, an associate professor at SUNY Upstate Medical University and the study’s lead author, said in a press release."
Spokane Clinic Gives Patients with Neurological Disorders
Options to Join Clinical Trials
The Spokesman-Review
A Spokane, WA, biomedical research group has waded into multiple clinical trials for new treatments to slow or more effectively treat Parkinson’s and other neurological conditions. Since 2018, these trials have included more than 100 participants: Inland Northwest Research, owned by neurologist Dr. Jason Aldred, is also a Parkinson’s specialist at Selkirk Neurology.